NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/09/2025
Voltar para busca
Dado oficial do USPTO
MYRECIL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
19/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5
Data de depósito
24/03/2021
Data de registro
27/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
19/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
NZ
Examinador
TRUSILO, KELLY
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DECIMA HEALTH LIMITED
Representantes
Colin P Abrahams Law Office of Colin P Abrahams
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Plant extracts for use in manufacture of cosmeticsskin care preparationspharmaceuticals and nutraceuticals; biological extracts for use in the manufacture of cosmeticsskin care preparationspharmaceuticals and nutraceuticals; botanical extractsother than essential oilsfor use in the manufacture of cosmeticsskin care preparationspharmaceuticals and nutraceuticals; pollen or pollen-based extracts for use in the manufacture of cosmeticsskin care preparationspharmaceuticals and nutraceuticals; fermented extracts for use in the manufacture of cosmeticsskincare preparationspharmaceuticals and nutraceuticals
Classe 3
Cosmetics; cosmetic preparations for skin care; non-medicated skin care preparations; moisturizing skin creams and lotions; hair care preparations; anti-aging skin care preparations; cosmetic facial skin care preparations; facial cleansers; skin cleansers; skin toners for cosmetic use; moisturizers; beauty serums for cosmetic use; non-medicated scrubs for the face and body; cosmetic body care preparationsnon-medicated
Classe 5
Pharmaceutical preparations and substances for the treatment of skin conditions; pharmaceutical preparations and substances for the treatment of eczemapsoriasisdermatitisrosaceaacneactinic keratosismoleswoundslacerationsscarsphotodamageherpescorpus molluscumlupus; anti-fungal pharmaceutical preparations for treating skin disorders; anti-microbial pharmaceutical preparations for treating skin disorders; natural preparations in the nature of medicaments for skin treatment; dietary supplements; pollen or pollen-based extracts for medical or pharmaceutical use; ferments for medical or pharmaceutical purposes; dietary supplements containing pollen or pollen-based extracts; beehive extracts for medical or pharmaceutical use; medical or pharmaceutical preparations containing beehive extracts for treatment of skin conditions; pharmaceutical preparations containing plant extracts for treatment of skin conditions; nutraceutical preparations containing plant extracts for therapeutic or medical purposes as a dietary supplement
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/02/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/01/2023
FIMP
FINAL DISPOSITION PROCESSED
23/01/2023
GPNX
NOTIFICATION PROCESSED BY IB
28/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2022
PUBO
PUBLISHED FOR OPPOSITION
12/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2022
RFNT
REFUSAL PROCESSED BY IB
01/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/12/2021
RFRR
REFUSAL PROCESSED BY MPU
13/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/11/2021
CNRT
NON-FINAL ACTION WRITTEN
17/11/2021
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
16/11/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/11/2021
CNRT
NON-FINAL ACTION WRITTEN
10/11/2021
DOCK
ASSIGNED TO EXAMINER
01/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
29/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MYRECIL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.